Search Results 91-100 of 19296 for B cell lymphomas
Histologically proven large B-cell lymphoma including the following types defined by WHO 2016 (Swerdlow et al., 2016): · Relapsed or refractory disease after ...
Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma. Print details. Share; Facebook ...
... B-cell Non-Hodgkin Lymphomas. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information ...
... B-Cell Non-Hodgkin Lymphomas. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information ...
Giving paclitaxel albumin-stabilized nanoparticle formulation and rituximab may work better in treating patients with B-cell non-Hodgkin lymphoma. Participation ...
Evaluation of Etiologic Heterogeneity for Risk of Diffuse Large B-Cell Lymphoma Subtype Defined by Cell-of-Origin. ... B-cell lymphomas. Blood Cancer J. 2024 Oct ...
Developing the first genetic test to help guide the diagnosis and treatment of people with diffuse large B-cell lymphoma, the most common type of non-Hodgkin ...
Having a family history of lymphoma. Having a relative who has Waldenstrom macroglobulinemia or another type of B-cell lymphoma might increase your risk. By ...
Ansell's lymphoma research program, which focuses on the TME and B cell cancer biology, has produced over 450 journal articles, including the 2021 paper in JCO ...
Brentuximab injection is also used together with other medicines (eg, lenalidomide, rituximab) to treat certain types of large B-cell lymphoma (including ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.